Métier Medical Ltd Annual Update 2015; Company President Elected to WHO Committee & First Product Orders Shipped

In 2015 Métier Medical widened its footprint as an advocate for safe injection policy and the use of safety engineered injection devices with the election of the Company’s US based President to the World Health Organisation’s committee to assist in the implementation of it’s global Safe Injection policy announced in February 2015.

Supporting the Company’s initiative, development of the Métier Medical Safe-T-Clip™ safety needle with patent pending Secure-Lok ™ locking mechanism was completed in 2015 and is designed to prevent the incidence of needlestick injury to healthcare workers. First orders have been shipped to South Africa and pending orders show a very solid market for the US on completion of FDA around February 2016. Further product development and capital raising will continue into 2016 as the Company aligns itself with the new initiatives of WHO and other international agencies requiring injection devices which feature both Reuse Prevention and Sharps Injury Prevention features.

ABOUT METIER MEDICAL

Needlestick injury and reuse is an endemic problem throughout the developed and developing world with up to 800,000 needlestick injuries estimated in USA alone every year.

Governments globally are moving to legislate the mandatory use of safety syringes and Métier Medical Limited’s Safe-T-Point™ range of retractable syringes including the Safe-T-Point™ Insulin Syringe are a cost effective, safety option for the market.